Search
Displaying all 2 results
Maraviroc Action Pathway
smpdb.ca/view/SMP0125985Drug actionMaraviroc blocks HIV entry to the host cell by selectively binding to the human chemokine receptor (CCR5) present on the membrane of CD4 cells (T cells). … Maraviroc, known by the brand name Selzentry or Celsentri, is a chemokine receptor antagonist drug used to treat HIV-1 infections. It was developed by the drug company Pfizer.
Maraviroc Predicted Metabolism Pathway
smpdb.ca/view/SMP0174659MetabolicMetabolites of sildenafil are predicted with biotransformer.